Elucidating Immunometabolic Responses to HIV Infection that Increase TB or HBV Risk (R01 Clinical Trial Not Allowed)
HHS-NIH11
POSTED: 12/18/2024
UPDATED: 01/28/2026
DUE: 05/07/2026
The purpose of this notice of funding opportunity (NOFO) is to support research to elucidate how HIV-induced immunometabolic alterations, in a host suppressed on combination antiretroviral therapy (cA...
Translational Efforts to Advance Gene-based Therapies for Ultra-Rare Neurological and Neuromuscular Disorders (U01 - Clinical Trial Optional)
HHS-NIH11
POSTED: 12/18/2024
UPDATED: 12/18/2024
DUE: 10/08/2027
The Ultra-Rare Gene-Based Therapy (URGenT) network supports Investigational New Drug (IND)-enabling studies and planning activities for First-in-Human (FIH) clinical testing of gene-based or transcrip...
Supporting Talented Early Career Researchers in Genomics (R01 Clinical Trial Optional)
HHS-NIH11
POSTED: 12/16/2024
UPDATED: 12/16/2024
DUE: 02/26/2027
This Funding Opportunity Announcement is intended to identify and support research projects by exceptionally promising Early Stage Investigators with a long-term career interest in pursuing innovative...
NIDCD Research Grants for Translating Basic Research into Clinical Practice (R01 Clinical Trial Optional)
$500,000
HHS-NIH11
POSTED: 12/16/2024
UPDATED: 12/16/2024
DUE: 10/12/2027
This Funding Opportunity Announcement (FOA) is intended to provide an avenue for basic scientists, clinicians and clinical scientists to jointly initiate and conduct translational research projects wh...
Limited Competition: Small Grant Program for NHLBI K01/K08/K23/K25 Recipients (R03 Clinical Trial Optional)
$75,000
HHS-NIH11
POSTED: 12/16/2024
UPDATED: 12/16/2024
DUE: 01/07/2026
The purpose of this Notice of Funding Opportunity (NOFO) is to solicit current or recently completed NHLBI K01, K08, K23, and K25 awardees for small grant support to expand their current research obje...
D-START: Data Science Track Award for Research Transition (D/START) (R03-Clinical Trial Optional)
$100,000
HHS-NIH11
POSTED: 12/16/2024
UPDATED: 12/16/2024
DUE: 09/07/2027
Data science is an important cross-cutting research approach in the 2022 - 2026 NIDA Strategic Plan and increasing the capacity of experts in addiction related data science is critical. The purpose of...
Leveraging Network Infrastructure to Conduct Innovative Research for Women, Children, Pregnant and Lactating Women, and Persons with Disabilities (UG3/UH3 - Clinical Trial Optional)
HHS-NIH11
POSTED: 12/16/2024
UPDATED: 03/31/2025
DUE: 11/15/2027
The purpose of this Notice of Funding Opportunity (NOFO) is to leverage NICHD clinical research Network infrastructure relevant to infants, children, women, pregnant and lactating women, and persons w...
Toward Translation of Nanotechnology Cancer Interventions (TTNCI; R01 Clinical Trial Not Allowed)
HHS-NIH11
POSTED: 12/16/2024
UPDATED: 12/16/2024
DUE: 11/15/2027
Through this Notice of Funding Opportunity (NOFO), entitled "Toward Translation of Nanotechnology Cancer Interventions" (TTNCI), the National Cancer Institute (NCI) encourages applications for advance...
National Cancer Institute Program Project Applications for the Years 2023, 2024, and 2025 (P01 Clinical Trial Optional)
HHS-NIH11
POSTED: 12/14/2022
UPDATED: 02/12/2026
DUE: 05/26/2026
Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) invites applications for investigator-initiated Program Project (P01) applications. The proposed Program may ad...
Risk and Protective Factors of Family Health and Family Level Interventions (R01 Clinical Trial Optional)
HHS-NIH11
POSTED: 12/13/2024
UPDATED: 03/14/2025
DUE: 05/08/2027
The purpose of this initiative is to advance the science of minority health and health disparities by supporting research on family health and well-being and resilience. The NIMHD Research Framework r...